CA-PACKETFABRIC
9.12.2020 15:17:13 CET | Business Wire | Press release
PacketFabric , an innovator of on-demand connectivity to the secure, private internet, today announced it launched flat rate pricing for hybrid cloud connectivity across the U.S. and Europe. With this innovative pricing strategy, PacketFabric continues to lead the market disruption of networking and cloud computing.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201209005337/en/
PacketFabric’s new democratized pricing is $100 per month for hosted hybrid cloud connections up to 1Gbps, for both metro and long-haul capacity in the United States and Europe. With this new pricing strategy, PacketFabric is making cloud connectivity egalitarian across the tech landscape.
“Cloud is the future, and it shouldn’t be exclusive,” said PacketFabric CEO Dave Ward. “That’s why we sought a way to democratize it. Now with PacketFabric’s flat rate pricing, companies from emerging businesses to large enterprises can have affordable access to the cloud.”
According to Gartner, “cost optimization will be crucial to drive cloud adoption, and by 2024, all legacy applications will be migrated to public cloud infrastructure.”
“They say you can’t have it good, fast and cheap, but now you can have all three with PacketFabric’s flat rate, cloud connectivity pricing,” continued Ward. “We’ve been disrupting the market since we launched PacketFabric’s Network-as-a-Service (NaaS) platform in 2017, and we continue to lead the way forward.”
PacketFabric’s NaaS orchestrates and guarantees connectivity between collocation facilities, clouds, and offers private network interconnection across the globe. The NaaS platform is private, secure, reliable and scalable, plus it’s fully redundant. PacketFabric is a women-founded technology start-up, launched by industry veterans Jezzibell Gilmore, PacketFabric’s Chief Commercial Officer, and Anna Claiborne, Senior Vice President of Product and Engineering for PacketFabric.
Ward, a prolific technologist, expands on PacketFabric’s strategy in his recent blog post , “Democratizing Access to the Cloud, Disrupting the Business of Getting to the Cloud.”
About PacketFabric
PacketFabric redefines how the enterprise moves data by automating network connectivity services. Leveraging an entirely automated SDN-based network architecture and the latest in optical and packet switching technology, PacketFabric enables dynamic, real-time connectivity services between more than hundreds of premier colocation facilities across many global markets. The PacketFabric Network-as-a-Service (NaaS) platform delivers simple, cost-effective, and scalable network deployment via its advanced Application Program Interface (API) and web portal. PacketFabric was named one of the “10 Hottest Networking Startups in 2020” by CRN and a 2020 “Cool Vendor in Enhanced Internet Services and Cloud Connectivity” by Gartner. PacketFabric investors include NantWorks and Digital Alpha Advisors. For more information, visit packetfabric.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20201209005337/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom